Acute chest pain (ACP) is a common symptom that presents in clinical practice, often posing a diagnostic challenge. This symptom may indicate serious cardiovascular conditions, but it can also be a manifestation of gastrointestinal, musculoskeletal, or psychological disorders. Therefore, it is crucial to have a comprehensive understanding and approach to diagnosing ACP.
The initial evaluation of ACP should focus on identifying life-threatening conditions. A thorough history taking, physical examination, and basic investigations such as electrocardiogram (ECG) and chest radiographs are essential. The patient's age, risk factors, and the nature of the pain can guide the clinician towards certain diagnoses.
Further diagnostic testing is guided by the initial assessment. In cases where acute coronary syndrome (ACS) is suspected, cardiac biomarkers and stress testing may be required. For suspected pulmonary conditions, computed tomography (CT) and ventilation-perfusion scans can be beneficial. Gastrointestinal causes may warrant endoscopy or abdominal imaging.
Risk stratification tools can aid in the management of patients with ACP. Tools such as the HEART score and the TIMI risk score can help identify patients at high risk for adverse events, aiding in the decision for hospital admission or discharge.
Shared decision making is essential in managing ACP. After diagnostic testing and risk stratification, clinicians should discuss the potential benefits, risks, and uncertainties of different management strategies with patients. This approach ensures that patient values and preferences are incorporated into the management plan.
Diagnosing ACP requires a comprehensive approach, including initial assessment, diagnostic testing, risk stratification, and shared decision making. By adopting this method, clinicians can ensure that patients receive the most appropriate and effective care, ultimately improving patient outcomes.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation